Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC)
Conditions: COVID; COVID-19; SARS-CoV-2; SARS (Severe Acute Respiratory Syndrome) Interventions: Drug: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG); Other: Placebo; Drug: Remdesivir Sponsors: University of Minnesota; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); The International Network for Strategic Initiatives in Global HIV Trials Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Coronavirus | COVID-19 | Infectious Diseases | Research | SARS